A detailed history of Orbis Allan Gray LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Orbis Allan Gray LTD holds 1,268,112 shares of ALNY stock, worth $311 Million. This represents 2.25% of its overall portfolio holdings.

Number of Shares
1,268,112
Previous 721,053 75.87%
Holding current value
$311 Million
Previous $175 Million 99.09%
% of portfolio
2.25%
Previous 1.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$233.81 - $287.01 $128 Million - $157 Million
547,059 Added 75.87%
1,268,112 $349 Million
Q2 2024

Aug 14, 2024

BUY
$143.31 - $247.0 $103 Million - $178 Million
721,053 New
721,053 $175 Million
Q3 2023

Nov 14, 2023

BUY
$170.77 - $211.65 $6.52 Million - $8.08 Million
38,189 New
38,189 $6.76 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Orbis Allan Gray LTD Portfolio

Follow Orbis Allan Gray LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbis Allan Gray LTD, based on Form 13F filings with the SEC.

News

Stay updated on Orbis Allan Gray LTD with notifications on news.